查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1495976

全球神经假体市场 - 2024 年至 2029 年预测

Global Neuroprosthetics Market - Forecasts from 2024 to 2029
出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 130 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

2022年神经修復市场价值为40.52亿美元，预计复合年增长率为12.36%，到2029年市场规模将达到91.24亿美元。

神经假体是植入神经损伤患者体内以补充和恢復神经正常功能，从而帮助部分恢復正常身体功能的装置。全球神经病变的增加是预计在预测期内推动神经修復市场成长的关键因素之一。该市场包括脑机介面、脊髓刺激设备、人工电子耳、深层脑部刺激器和视网膜植入等各种类型的设备。主要参与企业包括成熟的医疗设备公司和新兴新兴企业。

FDA 和 EMA 等卫生当局的监管核准保证了安全性和有效性。技术挑战包括复杂神经网路设备的开发、伦理考量、隐私问题和社会接受度。此外，随着糖尿病患者数量的增加，许多人正遭受神经损伤，预计未来几年对神经假体的需求将迅速增加。此外，多年来听力损失人数大幅增加，预计未来几年将大幅增加，进一步促进评估期间神经修復市场的成长。

市场驱动因素：

  • 由于神经系统疾病的增加，神经假体市场预计将扩大。

全球患有神经病变的人数正在增加，这是预计在预测期内推动神经假体需求的主要原因之一。根据世界卫生组织 (WHO) 的数据，过去 30 年来，神经病变导致的死亡人数增加了近 39%。此外，神经病变患者的数量正在逐年增加，由于老年人口的增加、儿童死亡率的下降以及生存率和平均寿命的增加，预计未来该数字将进一步增加。

根据泛美卫生组织（PAHO）的资料，巴西每10万人的残障寿命（YLD）从2010年的784.06年增加到2019年的813.74年。在墨西哥，这数字从2010年的721.78增加到2019年的737.02。在美国，神经系统疾病死亡人数从2010年的每10万人39.29人增加到2019年的47.39人，增加超过20%。

此外，阿兹海默症、失智症和帕金森氏症等疾病是成长最快的神经系统疾病。例如，根据泛美卫生组织的数据，加拿大每10万人的伤残调整生命年（DALY）从2010年的351.30跃升至2019年的415.70，成长超过18%。

  • 听力损失的日益普遍可能会导致对义肢假体的需求激增。

由于神经助听器用于治疗严重听力损失，全球听力损失盛行率的不断上升是预计未来几年促进神经修復市场成长的关键因素。根据世界卫生组织的资料，巴西听力损失的绝对人数从2008年的1000万增加到2018年的1300万。

在中国，听力损失人数从2008年的7400万增加到2018年的9600万，在印度，这一数字从2008年的7650万增加到2018年的1亿。世界卫生组织预测，听力损失人数将从2020年的4.3亿增加到2050年的7亿人以上。预计这将导致对义肢假体的需求大幅增加。

预计亚太地区将占据主要市场占有率。

从地理上看，由于该地区神经病变病例数量不断增加，预计亚太地区将占据重要的市场占有率。此外，高品质的医疗保健系统和容易接触到患者，使诊断和治疗更加有力，也是该地区神经修復术市场规模巨大的重要原因。由于听力损失盛行率上升，亚太地区预计将显着增长。

此外，根据世界卫生组织的资料，南亚残疾性听力损失的绝对人数将从2018年的1.31亿增加到2030年的1.76亿，并预计在2050年进一步增加到2.67亿。此外，由于该地区糖尿病患者数量迅速增加，导致大量患者神经和血管受损，预计评估期间亚太地区对义肢假体的需求将进一步激增。

主要发展

  • 2024 年 1 月 - 莱斯大学和休士顿卫理公会大学建立神经系统復原中心 (CNSR)，这是一个神经科学研究和治疗创新的跨学科合作中心。该中心旨在透过汇集科学家、临床医生、工程师和外科医生来改善神经护理，以解决中风恢復和脊髓损伤等医疗挑战。重点关注领域包括脑功能恢復、轻度创伤性脑损伤检测、运动功能恢復、平衡和生物回馈疗法训练。
  • 2023 年 3 月 - 全球植入式听力解决方案领导者 Cochlear 成为首家获得 ISO/IEC 27001资讯安全管理认证的听力植入製造商。此认证评估资料保护并表明科利耳对全球最佳实践的承诺。该认证还认可了科利耳在数位产品方面的高标准，包括连网型护理，透过智慧应用程式和软体解决方案提供便利的护理选择，提高外科医生对佩戴的信心，并优化术后临床表现，这表明了其承诺。
  • 2022 年 12 月 -萨斯喀彻尔省政府、卫生署和萨斯喀彻尔卫生局 (SHA) 启动了扩展人工植入计划，以帮助需要更换外部声音处理器的严重听力损失人士。根据该计划，您为每个处理器自付费用 840 美元，卫生署承担剩余费用（通常在 8,000 美元至 12,000 美元之间）。该计划将在接下来的几个月内覆盖约 70 个声音处理器，此后每年覆盖 50 个。预计2022-23年耗资44.6万美元，每年耗资30万美元。

目录

第一章简介

  • 市场概况
  • 市场定义
  • 调查范围
  • 市场区隔
  • 货币
  • 先决条件
  • 基准年和预测年时间表
  • 相关利益者的主要利益

第二章调查方法

  • 研究设计
  • 调查过程

第三章执行概述

  • 主要发现

第四章市场动态

  • 市场驱动因素
  • 市场限制因素
  • 波特五力分析
  • 产业价值链分析
  • 分析师观点

第五章全球神经义肢市场：依类型

  • 介绍
  • 输出神经假体
  • 输入神经假体

第六章 全球神经义肢市场：依技术分类

  • 介绍
  • 脑深部电刺激疗法
  • 脊髓刺激
  • 荐椎神经刺激
  • 经颅磁刺激
  • 迷走神经刺激

第七章 全球神经义肢市场：依应用分类

  • 介绍
  • 听觉处理障碍
  • 帕金森氏症
  • 癫痫
  • 眼科疾病
  • 循环系统疾病
  • 麻痹
  • 阿兹海默症
  • 其他的

第八章全球神经义肢市场：依地区划分

  • 介绍
  • 北美洲
  • 南美洲
  • 欧洲
  • 中东/非洲
  • 亚太地区

第九章竞争环境及分析

  • 主要企业及策略分析
  • 市场占有率分析
  • 合併、收购、协议和合作
  • 竞争对手仪表板

第十章 公司简介

  • SenArs
  • LivaNova PLC
  • Medtronic PLC
  • Sonova Holding AG
  • Boston Scientific Corporation
  • Cochlear Ltd
  • Demant AS
  • Abbott Laboratories
  • NeuroPace, Inc.
  • BrainGate
  • NDI Medical
简介目录
Product Code: KSI061612097

The global neuroprosthetics market is evaluated at US$4.052 billion for the year 2022 and is projected to grow at a CAGR of 12.36% to reach the market size of US$9.124 billion by 2029.

Neuroprosthetics are devices implanted in patients with neural damage to compensate for and restore the normal functioning of the nerves, which consequently help in partially restoring normal bodily functions. The rising incidences of neurological disorders worldwide are one of the major factors anticipated to boost the global neuroprosthetics market growth during the forecast period. The market includes various types of devices, such as brain-machine interfaces, spinal cord stimulators, cochlear implants, deep brain stimulators, and retinal implants. Key players include established medical device companies and emerging startups.

Regulatory approvals from health authorities like the FDA and EMA ensure safety and efficacy. Technological challenges include developing devices for complex neural networks, ethical considerations, privacy issues, and societal acceptance. Furthermore, the growing number of diabetes patients, leading to nerve damage in many people, is also expected to lead to a surge in demand for neuroprosthetics in the coming years. Moreover, the number of people with disabling hearing loss has been increasing substantially over the years, and its projected rapid rise in the coming years is further anticipated to augment the global neuroprosthetics market growth during the assessment period.

Market Drivers:

  • Rising cases of neurological disorders are expected to increase the global neuroprosthetics market.

The number of people suffering from neurological disorders is on the rise worldwide and is one of the prominent reasons anticipated to drive the demand for neuroprosthetics during the forecast period. According to the World Health Organization, the number of deaths caused by neurological disorders has increased by nearly 39% in the last 30 years. It has also been stated that an increase in the number of patients with neurological disorders has been seen over the years, while the number of cases is further projected to grow in the coming years owing to a growing elderly population, a decrease in child mortality, and rise in the survival rate and life expectancy.

As per data from the Pan America Health Organization (PAHO), the years lived with disability (YLDs) per 100,000 population in Brazil increased from 784.06 years in 2010 to 813.74 years in 2019. In Mexico, it increased from 721.78 years in 2010 to 737.02 years in 2019. In the United States, the deaths from neurological disorders increased from 39.29 deaths per 100,000 population in 2010 to 47.39 deaths in 2019, witnessing an increase of more than 20%.

Furthermore, diseases such as Alzheimer's, dementia, and Parkinson's disease are some of the neurological disorders spreading fast. For instance, according to PAHO, Canada has witnessed a surge in disability-adjusted life years (DALYs) per 100,000 population from 351.30 in 2010 to 415.70 in 2019, growing by more than 18%.

  • The growing prevalence of hearing loss would lead to a surge in neuroprosthetics demand.

As neuroprosthetics are used in severe hearing loss, the increasing prevalence of hearing loss worldwide is a significant factor expected to augment the global neuroprosthetics market growth in the coming years. According to data from the WHO, the absolute number of people with hearing loss in Brazil has increased from 10 million in 2008 to 13 million in 2018.

In China, the number of people with hearing loss increased from 74 million in 2008 to 96 million in 2018, while in India, this number increased from 76.5 million in 2008 to 100 million in 2018. WHO has projected that people with disabling hearing loss will increase from 430 million in 2020 to more than 700 million by 2050. This is expected to surge the demand for neuroprosthetics significantly.

Asia Pacific region is projected to have a major market share.

Geographically, the Asia Pacific region is anticipated to hold a significant market share owing to the rising cases of neurological disorders in the region. Furthermore, the presence of a quality healthcare system and its accessibility to patients make diagnosis and treatment stronger, which is another prominent reason for the large market size of neuroprosthetics in the region. The Asia Pacific region is anticipated to witness substantial growth due to the rising prevalence of hearing loss in the region.

Additionally, according to data from the WHO, the absolute number of people with disabling hearing loss in South Asia is projected to increase from 131 million in 2018 to 176 million in 2030 and further to 267 million in 2050. Furthermore, the rapidly growing cases of diabetes in the region are leading to damage to the nerves and blood vessels of a large number of patients, which is further projected to surge the demand for neuroprosthetics in the Asia Pacific region during the assessment period.

Key Developments:

  • January 2024- Rice University and Houston Methodist established the Center for Neural Systems Restoration (CNSR), a joint interdisciplinary center for neuroscience research and treatment innovation. The center aims to improve neurological care by bringing together scientists, clinicians, engineers, and surgeons to tackle medical challenges like stroke recovery and spinal cord injury. Key focus areas include brain function restoration, mild traumatic brain injury detection, mobility restoration, balance, and biofeedback training. The Houston Methodist facility included operating rooms, a laboratory for diagnosis and assessment, device fabrication and testing, and education and training opportunities.
  • March 2023- Cochlear, a global leader in implantable hearing solutions, become the first hearing implant manufacturer to receive ISO/IEC 27001 certification for information security management. This certification assesses data protection and demonstrates Cochlear's commitment to global best practices. The certification also signifies Cochlear's commitment to high standards in digital products, such as its Connected Care, which offers convenient care options through Smart Apps and software solutions, enhancing surgeons' confidence in device placement and optimizing postoperative clinical performance.
  • December 2022- The Saskatchewan Government, the Ministry of Health, and the Saskatchewan Health Authority (SHA) launched an expanded Cochlear Implant Program to assist individuals with severe hearing loss who need their external sound processor replaced. The program allows individuals to co-pay $840 per processor, with the Ministry of Health covering the remaining cost, typically $8,000 to $12,000. The program covers approximately 70 sound processors in the next few months and 50 devices per year thereafter. The program is expected to cost $446,000 in 2022-23, with an annual cost of $300,000.

Market Segmentation:

By Type

  • Output Neural Prosthetics
  • Input Neural Prosthetics

By Technique

  • Deep Brain Stimulation
  • Spinal Cord Stimulation
  • Sacral Nerve Stimulation
  • Transcranial Magnetic Stimulation
  • Vague Nerve Stimulation

By Application

  • Auditory Processing Disorders
  • Parkison's Disease
  • Epilepsy
  • Ophthalmic Disease
  • Cardiovascular Disease
  • Paralysis
  • Alzheimer's Disease
  • Others

By Geography

  • North America
  • USA
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Others
  • Middle East and Africa
  • Saudi Arabia
  • UAE
  • Others
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Taiwan
  • Thailand
  • Indonesia
  • Others

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. Market Overview
  • 1.2. Market Definition
  • 1.3. Scope of the Study
  • 1.4. Market Segmentation
  • 1.5. Currency
  • 1.6. Assumptions
  • 1.7. Base and Forecast Years Timeline
  • 1.8. Key Benefits to the Stakeholder

2. RESEARCH METHODOLOGY

  • 2.1. Research Design
  • 2.2. Research Processes

3. EXECUTIVE SUMMARY

  • 3.1. Key Findings

4. MARKET DYNAMICS

  • 4.1. Market Drivers
  • 4.2. Market Restraints
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers
    • 4.3.2. Bargaining Power of Buyers
    • 4.3.3. Threat of New Entrants
    • 4.3.4. Threat of Substitutes
    • 4.3.5. Competitive Rivalry in the Industry
  • 4.4. Industry Value Chain Analysis
  • 4.5. Analyst View

5. GLOBAL NEUROPROSTHETICS MARKET BY TYPE

  • 5.1. Introduction
  • 5.2. Output Neural Prosthetics
    • 5.2.1. Market Opportunities and Trends
    • 5.2.2. Growth Prospects
    • 5.2.3. Geographic Lucrativeness
  • 5.3. Input Neural Prosthetics
    • 5.3.1. Market Opportunities and Trends
    • 5.3.2. Growth Prospects
    • 5.3.3. Geographic Lucrativeness

6. GLOBAL NEUROPROSTHETICS MARKET BY TECHNIQUE

  • 6.1. Introduction
  • 6.2. Deep Brain Stimulation
    • 6.2.1. Market Opportunities and Trends
    • 6.2.2. Growth Prospects
    • 6.2.3. Geographic Lucrativeness
  • 6.3. Spinal Cord Stimulation
    • 6.3.1. Market Opportunities and Trends
    • 6.3.2. Growth Prospects
    • 6.3.3. Geographic Lucrativeness
  • 6.4. Sacral Nerve Stimulation
    • 6.4.1. Market Opportunities and Trends
    • 6.4.2. Growth Prospects
    • 6.4.3. Geographic Lucrativeness
  • 6.5. Transcranial Magnetic Stimulation
    • 6.5.1. Market Opportunities and Trends
    • 6.5.2. Growth Prospects
    • 6.5.3. Geographic Lucrativeness
  • 6.6. Vague Nerve Stimulation
    • 6.6.1. Market Opportunities and Trends
    • 6.6.2. Growth Prospects
    • 6.6.3. Geographic Lucrativeness

7. GLOBAL NEUROPROSTHETICS MARKET BY APPLICATION

  • 7.1. Introduction
  • 7.2. Auditory Processing Disorders
    • 7.2.1. Market Opportunities and Trends
    • 7.2.2. Growth Prospects
    • 7.2.3. Geographic Lucrativeness
  • 7.3. Parkison's Disease
    • 7.3.1. Market Opportunities and Trends
    • 7.3.2. Growth Prospects
    • 7.3.3. Geographic Lucrativeness
  • 7.4. Epilepsy
    • 7.4.1. Market Opportunities and Trends
    • 7.4.2. Growth Prospects
    • 7.4.3. Geographic Lucrativeness
  • 7.5. Ophthalmic Disease
    • 7.5.1. Market Opportunities and Trends
    • 7.5.2. Growth Prospects
    • 7.5.3. Geographic Lucrativeness
  • 7.6. Cardiovascular Disease
    • 7.6.1. Market Opportunities and Trends
    • 7.6.2. Growth Prospects
    • 7.6.3. Geographic Lucrativeness
  • 7.7. Paralysis
    • 7.7.1. Market Opportunities and Trends
    • 7.7.2. Growth Prospects
    • 7.7.3. Geographic Lucrativeness
  • 7.8. Alzheimer's Disease
    • 7.8.1. Market Opportunities and Trends
    • 7.8.2. Growth Prospects
    • 7.8.3. Geographic Lucrativeness
  • 7.9. Others
    • 7.9.1. Market Opportunities and Trends
    • 7.9.2. Growth Prospects
    • 7.9.3. Geographic Lucrativeness

8. GLOBAL NEUROPROSTHETICS MARKET BY GEOGRAPHY

  • 8.1. Introduction
  • 8.2. North America
    • 8.2.1. By Type
    • 8.2.2. By Technique
    • 8.2.3. By Application
    • 8.2.4. By Country
      • 8.2.4.1. USA
        • 8.2.4.1.1. Market Opportunities and Trends
        • 8.2.4.1.2. Growth Prospects
      • 8.2.4.2. Canada
        • 8.2.4.2.1. Market Opportunities and Trends
        • 8.2.4.2.2. Growth Prospects
      • 8.2.4.3. Mexico
        • 8.2.4.3.1. Market Opportunities and Trends
        • 8.2.4.3.2. Growth Prospects
  • 8.3. South America
    • 8.3.1. By Type
    • 8.3.2. By Technique
    • 8.3.3. By Application
    • 8.3.4. By Country
      • 8.3.4.1. Brazil
        • 8.3.4.1.1. Market Opportunities and Trends
        • 8.3.4.1.2. Growth Prospects
      • 8.3.4.2. Argentina
        • 8.3.4.2.1. Market Opportunities and Trends
        • 8.3.4.2.2. Growth Prospects
      • 8.3.4.3. Others
        • 8.3.4.3.1. Market Opportunities and Trends
        • 8.3.4.3.2. Growth Prospects
  • 8.4. Europe
    • 8.4.1. By Type
    • 8.4.2. By Technique
    • 8.4.3. By Application
    • 8.4.4. By Country
      • 8.4.4.1. Germany
        • 8.4.4.1.1. Market Opportunities and Trends
        • 8.4.4.1.2. Growth Prospects
      • 8.4.4.2. France
        • 8.4.4.2.1. Market Opportunities and Trends
        • 8.4.4.2.2. Growth Prospects
      • 8.4.4.3. United Kingdom
        • 8.4.4.3.1. Market Opportunities and Trends
        • 8.4.4.3.2. Growth Prospects
      • 8.4.4.4. Others
        • 8.4.4.4.1. Market Opportunities and Trends
        • 8.4.4.4.2. Growth Prospects
  • 8.5. Middle East and Africa
    • 8.5.1. By Type
    • 8.5.2. By Technique
    • 8.5.3. By Application
    • 8.5.4. By Country
      • 8.5.4.1. Saudi Arabia
        • 8.5.4.1.1. Market Opportunities and Trends
        • 8.5.4.1.2. Growth Prospects
      • 8.5.4.2. UAE
        • 8.5.4.2.1. Market Opportunities and Trends
        • 8.5.4.2.2. Growth Prospects
      • 8.5.4.3. Others
        • 8.5.4.3.1. Market Opportunities and Trends
        • 8.5.4.3.2. Growth Prospects
  • 8.6. Asia Pacific
    • 8.6.1. By Type
    • 8.6.2. By Technique
    • 8.6.3. By Application
    • 8.6.4. By Country
      • 8.6.4.1. China
        • 8.6.4.1.1. Market Opportunities and Trends
        • 8.6.4.1.2. Growth Prospects
      • 8.6.4.2. India
        • 8.6.4.2.1. Market Opportunities and Trends
        • 8.6.4.2.2. Growth Prospects
      • 8.6.4.3. Japan
        • 8.6.4.3.1. Market Opportunities and Trends
        • 8.6.4.3.2. Growth Prospects
      • 8.6.4.4. South Korea
        • 8.6.4.4.1. Market Opportunities and Trends
        • 8.6.4.4.2. Growth Prospects
      • 8.6.4.5. Taiwan
        • 8.6.4.5.1. Market Opportunities and Trends
        • 8.6.4.5.2. Growth Prospects
      • 8.6.4.6. Thailand
        • 8.6.4.6.1. Market Opportunities and Trends
        • 8.6.4.6.2. Growth Prospects
      • 8.6.4.7. Indonesia
        • 8.6.4.7.1. Market Opportunities and Trends
        • 8.6.4.7.2. Growth Prospects
      • 8.6.4.8. Others
        • 8.6.4.8.1. Market Opportunities and Trends
        • 8.6.4.8.2. Growth Prospects

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 9.1. Major Players and Strategy Analysis
  • 9.2. Market Share Analysis
  • 9.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 9.4. Competitive Dashboard

10. COMPANY PROFILES

  • 10.1. SenArs
  • 10.2. LivaNova PLC
  • 10.3. Medtronic PLC
  • 10.4. Sonova Holding AG
  • 10.5. Boston Scientific Corporation
  • 10.6. Cochlear Ltd
  • 10.7. Demant AS
  • 10.8. Abbott Laboratories
  • 10.9. NeuroPace, Inc.
  • 10.10. BrainGate
  • 10.11. NDI Medical